Cancer Care

If you have cancer, you want to be sure you are getting care from the best.

That's why people from all over the region, across the country and even worldwide, come to Nebraska Medicine for their cancer care.

Nebraska Medicine provides the most comprehensive cancer care in the region using the most advanced and innovative treatments.

Nebraska Medicine and the University of Nebraska Medical Center (UNMC) are proud to announce the opening of the new Fred & Pamela Buffett Cancer Center in the spring 2017 to ensure Nebraskans and patients throughout the region have convenient and quick access to the latest breakthroughs in cancer therapy.

One of the cornerstones of the Fred & Pamela Buffett Cancer Center is the integration of clinical medicine with high-tech cancer research to accelerate new therapies for patients.

The new facility will include three areas dedicated to cancer: a 10-story, 98-laboratory research tower named the Suzanne and Walter Scott Cancer Research Tower; an eight-story, 108-bed inpatient treatment center named the C.L. Werner Cancer Hospital; and a multidisciplinary outpatient center. Patients undergoing cancer treatment at Nebraska Medicine also have access to our 24/7 Infusion Center at the Peggy D. Cowdery Patient Care Center, which serves as both a treatment center and 24/7 urgent-care-type facility. A rare offering in the region.

Service Options

Patient Guides

Why Consider Nebraska Medicine for Your Cancer Treatment

Guide You Through The Care Process

Today, there are a multitude of choices available for cancer treatment. Our cancer experts us a multi-disciplinary approach to care with a team of experts who will help you navigate through the many decisions available in cancer treatment including surgery, chemotherapy, radiation therapy, targeted therapies and immunotherapy. They will develop a personalized treatment plan in a collaborative approach based on your cancer type and personal wishes.

Access to Newest Treatments

Our cancer specialists use some of the most current and advanced therapies for treating cancer. This includes diagnostic and treatment techniques like personalized medicine, targeted therapies and immunotherapy, which we believe hold the future for modern-day cancer care.

Personalized medicine is based on the premise that one size doesn’t fit all, but it employs therapies based on a person’s unique genetic makeup. Instead of treating each patient with the same protocols based on the type of cancer he or she has, personalized medicine uses therapies that target specific genes or gene mutations, allowing for therapies that are tailored to the individual patient. These targeted therapies attack tumors with minimal harm to healthy tissue.

Researchers at Nebraska Medicine are also very involved in the development of immunotherapies. Immunotherapy is a personalized treatment approach that harnesses a patient’s own immune cells to kill cancer, avoiding much of the toxicity of current standard therapies such as chemotherapy.

Nebraska Medicine Employs the Largest Group of Medical Oncologists in the Region

Medical oncologists are doctors who are trained in cancer care and treatment. Our medical oncologists go one step further. They are trained in targeted disease specialties, making each an expert in their specific type of cancer and up-to-date with the best chemotherapy and combined treatment options. Chemotherapy treatments today have greatly improved and side effects have been minimized. Our specialists will ensure you receive the right treatment at the right time, with the fewest side effects and the best outcomes.

Access to Leading Edge Research and Clinical Trials

Many of our specialists are very involved in research to find new treatments and cures for all types of cancer. This affords our doctors the opportunity to take part in some of the most current clinical trials, giving you early access to the newest drugs and most advanced treatment options before they become widely available. Using the most advanced biomedical and technical tools allows for targeted medicine and personalized therapies for each patient. Research areas of focus include:

  • Genome Research
  • Regenerative Medicine
  • Translational Research
  • Clinical Research

Financial Guidance

When you seek treatment here, we pair you up with a financial counselor specially trained in all the costs and funding sources for cancer-related illnesses.

Addressing Your Personal Care Needs

Addressing a patient’s physical, educational, emotional and spiritual needs are important aspects of providing a more complete and holistic approach to care. A host of amenities and supportive services are available to help meet these needs. This includes personal care services such as wigs, wig fittings, prosthetic and bra fittings, yoga, massage therapy, skin care and make-up lessons specifically geared for people with or recovering from cancer are also provided in a private setting.

Cancer Support Services

Finding out that you have cancer can be a very emotional and difficult time. You will likely have many questions and issues to work through. We will be with you every step of the way. Nebraska Medicine offers a host of cancer support services to help you with your physical, emotional, educational and financial needs.

We're Here for You Long After Your Treatment

Our Survivorship Clinic is designed to help you deal with the emotional and physical challenges cancer can leave behind such as fear of recurrence, physical and medical long-term side effects and helping you return to a normal life again. It will also help you transition back into the care of your primary care physician.

 

Accreditations and Awards

Our cancer services are accredited by the most prestigious organizations in the nation to treat the rarest forms of cancer, tumors and malignancies.

 

The American College of Surgeons Commission on Cancer (CoC)

CoC accreditation challenges cancer programs to enhance the care they provide by addressing patient-centered needs and measuring the quality of the care they deliver against national standards.

 

The National Cancer Institute (NCI)

As the only National Cancer Institute-designated cancer center in Nebraska, the Fred & Pamela Buffett Cancer Center provides the best in science and clinical practice. Our goal is to become an NCI “Comprehensive Cancer Center,” a top designation shared by only 45 centers in the U.S.

The National Cancer Institute (NCI) is part of the National Institutes of Health (NIH), which is one of 11 agencies that compose the Department of Health and Human Services (HHS). The NCI, established under the National Cancer Institute Act of 1937, is the Federal Government’s principal agency for cancer research and training. The National Cancer Act of 1971 broadened the scope and responsibilities of the NCI and created the National Cancer Program. Over the years, legislative amendments have maintained the NCI authorities and responsibilities and added new information dissemination mandates as well as a requirement to assess the incorporation of state-of-the-art cancer treatments into clinical practice.

 

The National Comprehensive Cancer Network (NCCN)

The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 25 of the world’s leading cancer centers devoted to patient care, research, and education, is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers.

World-renowned experts from NCCN Member Institutions diagnose and treat patients with a broad spectrum of cancers and are recognized for dealing with complex, aggressive, or rare cancers. NCCN Member Institutions pioneered the concept of the multidisciplinary team approach to patient care and conduct innovative research that contributes significantly to understanding, diagnosing, and treating cancer. NCCN programs offer access to expert physicians, superior treatment, and quality and safety initiatives that continuously improve the effectiveness and efficiency of cancer care.

 

The American Society of Clinical Oncology Quality Oncology Practice Initiative

Nebraska Medicine has been recognized by the Quality Oncology Practice Initiative (QOPI®) Certification Program, an affiliate of the American Society of Clinical Oncology. The QOPI® Certification Program (QCP™) certifies oncology practices that meet nationally recognized standards for cancer care. This certification reaffirms our commitment to providing patients with high quality cancer care. Learn more about our certification.

 

Blue Cross Blue Shield of Nebraska Blue Distinction Center for Complex & Rare Cancers

First and only hospital in the state to receive the Blue Cross and Blue Shield of Nebraska, Blue Distinction Center for Complex and Rare Cancers.Blue Distinction Centers for Complex and Rare Cancers were developed in strategic collaboration with the National Comprehensive Cancer Network (NCCN) and input from a panel of leading clinicians and professional organizations. This program evaluates facilities on patient assessment, treatment planning, complex inpatient care and major surgical treatments for adults; all delivered by teams with distinguished expertise and subspecialty training for complex and rare cancers.

  • Adult Bone Marrow/Stem Cell
  • Pediatric Bone Marrow/Stem Cell
  • Acute Leukemia - Inpatient, Non-Surgical
  • Bladder Cancer
  • Bone Cancer - Primary
  • Brain Cancer - Primary
  • Esophageal Cancer
  • Gastric Cancer
  • Head and Neck Cancers
  • Liver Cancer - Primary
  • Pancreatic Cancer
  • Rectal Cancer
  • Soft Tissue Sarcomas
  • Thyroid Cancer

 

Big Ten Cancer Research Consortium

The Big Ten cancer centers have united to transform the conduct of cancer research through collaborative, hypothesis-driven, highly translational oncology trials that leverage the scientific and clinical expertise of Big Ten universities. The Big Ten Cancer Research Consortium creates a unique team-research culture to drive science rapidly from ideas to treatment-changing paradigms. Within this innovative environment, today’s research leaders collaborate with and mentor the research leaders of tomorrow with the unified goal of improving the lives of all patients with cancer.

 

U.S. News and World Report

Nebraska Medicine has been ranked among the nation’s best hospitals in cancer by U.S. News and World Report in 2012, 2013, 2014 and 2016. In 2015, 75% of the top cancer doctors in Nebraska according to U.S. News & World Report, worked at Nebraska Medicine.